Diiron μ-aminocarbyne compounds, 1a-e, are prepared in two steps from Fe 2 Cp 2 (CO) 4 , negating the need for difficult purification procedures of intermediate species; they are efficiently isolated by alumina chromatography. Minor amounts of μ-aminocarbyne aryl isocyanide compounds, 2a-c, are obtained as side products. The structures of the cations in 1a,c,e are calculated using DFT; the carbyne carbon is generally predicted to be the thermodynamic site of hydride addition, in agreement with a previous experimental finding concerning 1a. Accordingly, the reaction of 1e with NaBH 4 affords a bridging aminocarbene complex, 4, in 85 % yield. Otherwise, the reaction of 1c with NaBH 4 yields the aminocarbyne-cyclopentadiene derivative 3 (70 %), presumably as a consequence of the [a] Scheme 1. Regioselective additions of nucleophiles to the diiron aminocarbyne complex 1a. Results and DiscussionThe commercial compound [Fe 2 Cp 2 (CO) 4 ] was reacted with the appropriate isocyanide, in a ca. 3:2 molar ratio, in acetonitrile solution. [16] The reactions with alkyl isocyanides were conducted under reflux conditions, whereas the reactions with aryl isocyanides proceeded at room temperature. The resulting mixtures were dried under vacuum and the residues were dissolved in dichloromethane and then treated with methyl triflate, thus affording the μ-aminocarbyne complexes 1a-e (Scheme 2). The difficult isolation of the monoisocyanide intermediates (see the Introduction) was unnecessary. The final products 1a-e were efficiently purified by alumina chromatography and were then isolated as microcrystalline, air-stable compounds in 65-92 % yields. The synthesis of 1c-e was accompanied by the side formation of minor products derived from di-isocyanide species, 2a-c. Compounds 2a-c were recovered by the chromatography in 3-12 % yields, although 2a was formerly reported as being Scheme 2. Synthesis of diiron μ-aminocarbyne complexes.Eur. J. Inorg. Chem. 2018, 960-971 www.eurjic.org
Recently, the research activity in the field of the stereospecific polymerization of conjugated dienes has focused on the use of catalysts based on organometallic complexes having a well-defined structure and containing ligands of various types (e.g., phosphines, bis-imines, and pyridylimines), since it has been observed that the nature of the ligand, as expected on the basis of the diene polymerization mechanism proposed several years ago by Porri, is able to exert a strong influence on the polymerization regioand stereoselectivity, on the polymer molecular weights and their distribution, and in some cases to impart a living feature to the catalysts themselves. In this Perspective we highlight the most recent results obtained in this field and discuss possible future developments in this area.
Although ferrocene derivatives have attracted considerable attention as possible anticancer agents, the medicinal potential of diiron complexes has remained largely unexplored. Herein, we describe the straightforward multigram‐scale synthesis and the antiproliferative activity of a series of diiron cyclopentadienyl complexes containing bridging vinyliminium ligands. IC50 values in the low‐to‐mid micromolar range were determined against cisplatin sensitive and resistant human ovarian carcinoma (A2780 and A2780cisR) cell lines. Notable selectivity towards the cancerous cells lines compared to the non‐tumoral human embryonic kidney (HEK‐293) cell line was observed for selected compounds. The activity seems to be multimodal, involving reactive oxygen species (ROS) generation and, in some cases, a fragmentation process to afford monoiron derivatives. The large structural variability, amphiphilic character and good stability in aqueous media of the diiron vinyliminium complexes provide favorable properties compared to other widely studied classes of iron‐based anticancer candidates.
The molecular structure of 1,10-phenanthroline-5,6-dione has been determined by X-ray diffraction analysis. The compound reacts with the tetrachlorides of Group 4 metals affording adducts of general formula [MCl 4 (C 12 H 6 N 2 O 2 )] (M = Ti, Zr or Hf) and [(MCl 4 ) 2 (C 12 H 6 N 2 O 2 )] (M = Ti or Hf), N,NЈ-and N,NЈ,O,OЈ-co-ordinated respectively. The compound [HfCl 4 (C 12 H 6 N 2 O 2 )] is reactive towards TiCl 4 affording the bimetallic compound [Cl 4 Hf(C 12 H 6 N 2 O 2 )-TiCl 4 ]. The reaction of the dione with bis-cyclopentadienyl derivatives of titanium(), zirconium(), [MCp 2 (CO) 2 ], and vanadium(), VCp 2 , affords derivatives O,OЈ-co-ordinated to the MCp 2 moiety. By reaction of [TiCp 2 -(C 12 H 6 N 2 O 2 )] with [TiCp 2 (CO) 2 ] the bimetallic derivative [(TiCp 2 ) 2 (C 12 H 6 N 2 O 2 )] is obtained, which is suggested to contain two TiCp 2 fragments, O,OЈ-and N,NЈ-co-ordinated to 1,10-phenanthroline-5,6-dione. The [MCp 2 -(C 12 H 6 N 2 O 2 )] (M = Ti, Zr or V) derivatives react with MЈCl 4 (MЈ = Ti or Hf) to give [Cp 2 M(C 12 H 6 N 2 O 2 )MЈCl 4 ] bimetallics.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.